Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Why is the Artemis 2 rocket launch different from all other rocket launches? - 2Finding Europe's Head Traveler Objections: An Excursion Through Famous Attractions
- 36 Web-based Staple Help You Can Trust
- 4Moon rush: These private spacecraft will attempt lunar landings in 2026
- 5Exploring the Difficulties of Beginning a Family: Individual Experiences
- Most loved Seared Chicken: Which Chain Rules?
- Find the Marvels of the World with These Travels
- 'Everyone in this prison has had family killed or shot'
- The most effective method to Pick the Ideal Lab Precious stone Wedding band
- Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes
- Inflammatory Merz remarks on migrants' violence against women slammed
- Venezuelans in Madrid celebrate Maduro's capture
- A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
- Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
